Showing results (331-340 of 521) with videos related to

Sort By:
Pageof 53
PLOS Global Public Health|November 8, 2023
Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regionsLiã Bárbara Arruda, Hayley Beth Free, David Simons, et al.
Travel Medicine and Infectious Disease|June 30, 2020
Nosocomial outbreak of the Middle East Respiratory Syndrome coronavirus: A phylogenetic, epidemiological, clinical and infection control analysisMazin Barry, My Vt Phan, Layan Akkielah, et al.
Journal of Medical Entomology|May 18, 2023
The 2022 dengue outbreak in Bangladesh: hypotheses for the late resurgence of cases and fatalitiesNajmul Haider, Mohammad Nayeem Hasan, Ibrahim Khalil, et al.
The Journal of Infectious Diseases|April 13, 2012
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunitiesRuth McNerney, Markus Maeurer, Ibrahim Abubakar, et al.
The Lancet. Infectious Diseases|March 28, 2013
Drug-resistant tuberculosis: time for visionary political leadershipIbrahim Abubakar, Matteo Zignol, Dennis Falzon, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 14, 2016
Tuberculosis and mass gatherings-opportunities for defining burden, transmission risk, and the optimal surveillance, prevention, and control measures at the annual Hajj pilgrimageAlimuddin Zumla, Abdulaziz Bin Saeed, Badriah Alotaibi, et al.
Cell Death & Disease|March 13, 2021
Evidences for lipid involvement in SARS-CoV-2 cytopathogenesisRoberta Nardacci, Francesca Colavita, Concetta Castilletti, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|May 24, 2018
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosisDenise Rossato Silva, Margareth Dalcolmo, Simon Tiberi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 8, 2016
Classifying new anti-tuberculosis drugs: rationale and future perspectivesSimon Tiberi, Anna Scardigli, Rosella Centis, et al.
Plos One|November 13, 2012
Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising markerEmilie Borgström, Peter Andersen, Fredrik Atterfelt, et al.
Pageof 53